Zacks Investment Research upgraded shares of Ageas SA (NASDAQ:AGESY) from a hold rating to a buy rating in a research report released on Tuesday. They currently have $53.00 price objective on the stock.

According to Zacks, “Ageas, formerly known as Fortis, is an international insurance company. The Company has chosen to concentrate its business activities in Europe and Asia. Ageas offers international insurance services such as life and non-life, disability, and medical to individuals and groups. The Company also has subsidiaries in France, Germany, Turkey, Ukraine and Hong Kong. Ageas operates partnerships in Luxembourg, Italy, Portugal, China, Malaysia, India and Thailand. “

Ageas SA (NASDAQ AGESY) opened at 47.105 on Tuesday. Ageas SA has a 12 month low of $34.65 and a 12 month high of $47.45. The company has a 50 day moving average price of $46.65 and a 200 day moving average price of $42.79.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/ageas-sa-agesy-raised-to-buy-at-zacks-investment-research-2/1612328.html.

About Ageas SA

ageas SA is an international insurance company. The Company’s business segments include Belgium, the United Kingdom, Continental Europe, Asia and General Account. The Belgian insurance activities operate under the name of AG Insurance. The Company’s business in the United Kingdom is a national provider of Nonlife insurance solutions.

Get a free copy of the Zacks research report on Ageas SA (AGESY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Ageas SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ageas SA and related companies with Analyst Ratings Network's FREE daily email newsletter.